Log in

REGN Stock

Regeneron Pharmaceuticals, Inc. Common Stock
—

Price

Daily closes via Alpaca (IEX); today's point is the latest trade.

Key stats

Market cap—
Price alertSet alert →
Year to date—
Volume today—
Industry—
ExchangeNASDAQ

Valuation

P/E (trailing)19.8
Forward P/E13.8
Price / sales5.6
Price / book2.3
EPS (12 mo)$45.28
Dividend yield0.40%
Beta0.11

Financial health last 12 months

Revenue growth+18.6%
Earnings growth+8.4%
Gross margin86.8%
Net margin+28.5%
Return on equity15.1%
Debt / equity0.08

Hover a figure for what it means.

Analyst ratings Nov 2026 · 36 analysts

Consensus: Buy
Strong buy 8Buy 18 Hold 10Sell 0 Strong sell 0
MonthBuyHoldSellConsensus
Nov 2026 2610 0Buy
Oct 2026 2611 0Buy
Sep 2026 2612 0Buy
Aug 2026 2611 0Buy

Latest news

Headlines from the last 10 days via Finnhub; links open the publisher's article.

Next earnings

No report scheduled in the next 4 months.

Past earnings moves

No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.